sipuleucel t | PROVENGE® (sipuleucel-T)

Keyword	CPC	PCC	Volume	Score	Length of keyword
sipuleucel t	0.77	0.7	8105	38	12
sipuleucel	1.51	0.5	9357	7	10
t	1.11	0.5	9268	62	1

Keyword	CPC	PCC	Volume	Score
sipuleucel-t	1.99	0.5	3114	77
sipuleucel t prostate cancer	1.25	0.8	8117	62
sipuleucel t nejm	0.46	0.3	8248	35
sipuleucel t gba	0.43	0.9	1375	51
sipuleucel t cost	0.78	0.5	507	92
sipuleucel t vaccine	1.8	0.1	4445	20
sipuleucel t approval	1.78	0.1	1128	78
sipuleucel t indications	0.53	0.2	5225	52
sipuleucel t fda approval	1.15	0.5	1291	35
sipuleucel t side effects	1.81	0.1	6061	81
sipuleucel t pronunciation	1.01	1	8040	85
sipuleucel t immunotherapy	1.84	0.1	5110	9
sipuleucel-t package insert	1.32	0.4	4264	92
sipuleucel-t mechanism of action	0.1	0.9	7696	70
sipuleucel t prescribing information	1.76	0.7	1216	30
sipuleucel-t provenge	0.35	0.8	4666	1
sipuleucel-t prostate cancer	1.86	0.5	1711	20
sipuleucel-t vaccine	1.54	0.8	5950	95
sipuleucel-t fda	1.46	0.6	6564	44
sipuleucel-t cost	0.77	0.3	819	65

Search Results related to sipuleucel t on Search Engine

PROVENGE® (sipuleucel-T)
provenge.com

https://provenge.com/

WEBPROVENGE ® (sipuleucel-T) is a prescription medicine used to treat certain men with advanced prostate cancer. PROVENGE is an established cellular immunotherapy and is customized to each individual by using his own immune cells. IMPORTANT SAFETY INFORMATION.

DA: 96 PA: 1 MOZ Rank: 12

Questions and Answers - Provenge | FDA
fda.gov

https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/questions-and-answers-provenge

WEBPROVENGE (sipuleucel-T) is an autologous cellular immunotherapy designed to stimulate a patient’s own immune system against cancer. PROVENGE is manufactured in several steps.

DA: 25 PA: 93 MOZ Rank: 13

Sipuleucel-T - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Sipuleucel-T

WEBSipuleucel-T is indicated for the treatment of metastatic, asymptomatic or minimally symptomatic, metastatic castrate-resistant hormone-refractory prostate cancer (HRPC). Other names for this stage are metastatic castrate-resistant (mCRPC) and androgen independent (AI) or (AIPC).

DA: 89 PA: 28 MOZ Rank: 30

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate …
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa1001294

WEBJul 29, 2010 · Sipuleucel-T is an active cellular immunotherapy, a type of therapeutic cancer vaccine, 13 consisting of autologous peripheral-blood mononuclear cells (PBMCs), including antigen-presenting...

DA: 6 PA: 43 MOZ Rank: 51

Sipuleucel-T - NCI - National Cancer Institute
cancer.gov

https://www.cancer.gov/about-cancer/treatment/drugs/sipuleucel-t

WEBSipuleucel-T is approved to treat: Prostate cancer that has metastasized (spread to other parts of the body). It is used in men who have few or no symptoms and whose cancer is hormone-refractory (does not respond to hormone treatment). More About Sipuleucel-T

DA: 9 PA: 63 MOZ Rank: 54

Outcomes in men with metastatic castration-resistant prostate
nature.com

https://www.nature.com/articles/s41391-022-00493-x

WEBFeb 10, 2022 · Sipuleucel-T (Provenge ®) was the first therapeutic cancer vaccine to receive FDA approval in any solid malignancy, and was approved in April 2010 for the treatment of asymptomatic or minimally...

DA: 75 PA: 60 MOZ Rank: 78

Sipuleucel-T Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/sipuleucel-t.html

WEBDec 25, 2023 · Sipuleucel-T is an immunotherapy medicine used to treat advanced prostate cancer in men. Sipuleucel-T is made from a small amount of your own white blood cells, removed from blood that is drawn from your body. Sipuleucel-T is usually given after surgery or other treatments have failed.

DA: 77 PA: 78 MOZ Rank: 90

Sipuleucel-T | Memorial Sloan Kettering Cancer Center
mskcc.org

https://www.mskcc.org/cancer-care/patient-education/medications/adult/sipuleucel-t

WEBDec 12, 2022 · Sipuleucel-T. Adult Medication. This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. Brand Names: US. Provenge. What is this drug used for? It is used to treat prostate cancer.

DA: 59 PA: 94 MOZ Rank: 12

Real-World Effectiveness of Sipuleucel-T on Overall Survival in …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123060/

WEBMar 30, 2022 · Sipuleucel-T was the first immunotherapy approved by the US Food and Drug Administration (FDA) to treat asymptomatic or minimally symptomatic mCRPC. The androgen receptor-targeting agents (ARTAs) abiraterone acetate and enzalutamide were initially approved to treat mCRPC.

DA: 36 PA: 1 MOZ Rank: 10

Sipuleucel-T for the treatment of prostate cancer: novel insights …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925432/

WEBDec 20, 2017 · Sipuleucel-T is the only immune therapy currently approved for prostate cancer by the FDA, and the first therapeutic vaccine to be approved for any cancer [ 10 ]. It was FDA approved for asymptomatic or minimally symptomatic metastatic CRPC in 2010, and is manufactured by Dendreon Corporation [ 12 ].

DA: 76 PA: 70 MOZ Rank: 7